Close

Galectin (GALT) Misses Q3 EPS by 2c; Updates on GR-MD-02 Phase 1 Cohort 1

November 12, 2013 8:34 AM EST Send to a Friend
Galectin (NASDAQ: GALT) reported Q3 EPS of ($0.22), $0.02 worse than the analyst estimate of ($0.20).

Galectin reported that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login